First Page | Meta Content | |
---|---|---|
Document Date: 2013-05-29 15:44:25Open Document File Size: 133,06 KBShare Result on FacebookCompanyPublic Pemphigus / /CountryUnited States / Brazil / / /EventFDA Phase / /FacilityNational Institute of Arthritis / U.S. Department of Health and Human Services Public Health Service National Institute of Arthritis / / /IndustryTermdrug products / chemicals / /MedicalConditionblisters / Cuts / Pemphigus vulgaris / leave scars / cancer / disease / pus / scars / Pemphigoid / Paraneoplastic pemphigus / Public For More Information About Pemphigus / Skin blisters / serious disease / IgA pemphigus / last disease / Pemphigus / deep blisters / long-lasting blisters / Public Pemphigus foliaceus / blister / Pemphigus Q / pemphigus foliaceus / Such diseases / rare autoimmune diseases / infections / mouth blisters / skin diseases / Public Pemphigus / autoimmune skin disease / /MedicalTreatmentAntibiotics / /OrganizationInternational Pemphigus Foundation / Skin Diseases / Musculoskeletal and Skin Diseases / U.S. Food and Drug Administration / National Institute of Arthritis and Musculoskeletal / U.S. Department of Health and Human Services Public Health Service National Institute of Arthritis and Musculoskeletal / / /PositionGovernor / dentist / /ProductFDA-approved drug / /ProvinceOrStateMaryland / /RegionMediterranean / /Technologyantibodies / /URLwww.niams.nih.gov / www.accessdata.fda.gov/scripts/cder/drugsatfda.Drugs / www.fda.gov / /SocialTag |